The use of regional coordinating centers in large clinical trials: the DIG trial

被引:9
|
作者
Collins, JE
Martin, S
Kent, E
Liuni, C
Garg, R
Egan, D
机构
[1] Cooperat Studies Program Coordinating Ctr, VA Maryland Hlth Care Syst, Dept Vet Affairs, Perry Point, MD 21902 USA
[2] Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[3] Univ Alberta, Edmonton, AB, Canada
[4] St Josephs Hosp, Hamilton, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA
来源
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷 / 06期
关键词
randomized clinical trials; large simple trial; heart failure; digoxin; regional coordinating centers;
D O I
10.1016/S0197-2456(03)00101-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Digitalis Investigation Group (DIG) trial was a large simple clinical trial that involved 302 participating centers in the United States and Canada. In order to encourage participation by Canadian investigators, to provide additional help to what were expected to be largely research-inexperienced investigators in Canada, and to provide the study's data coordinating center with resources in Canada to deal with potentially different rules, regulations, and cultural differences, regional coordinating centers were established in four regions of Canada: the maritime provinces, Quebec, Ontario, and western Canada. Canadian centers recruited significantly better than their U.S. counterparts and had slightly better retention and follow-up. While it is not possible to declare that the regional coordinating centers were responsible for this improvement, it is believed that these regional centers did play a role. This role included being able to identify investigators who could be expected to do well, providing one-on-one training and instruction to investigators, and being able to solve problems and implement change in the relatively fewer centers in their regions. The regional coordinating center also reduced the intensity of the workload on the data coordinating center by serving as the primary point of contact for Canadian investigators. The use of regional coordinating centers in studies with a large number of participating centers is highly recommended. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:298S / 305S
页数:8
相关论文
共 50 条
  • [1] The role of the data coordinating center in the DIG trial
    Williford, WO
    Collins, JF
    Homey, A
    Kirk, G
    McSherry, F
    Spence, E
    Stinnett, S
    Howell, CL
    Garg, R
    Egan, D
    Yusuf, S
    CONTROLLED CLINICAL TRIALS, 2003, 24 (06): : 277S - 288S
  • [2] The role of the pharmacy coordinating center in the DIG trial
    Fye, CL
    Gagne, WH
    Raisch, DW
    Jones, MS
    Sather, MR
    Buchanan, SL
    Chacon, FR
    Garg, R
    Yusuf, S
    Williford, WO
    CONTROLLED CLINICAL TRIALS, 2003, 24 (06): : 289S - 297S
  • [3] The Coordinating Centers for Clinical Trials (KKS) and the KKS Network: Competence for Clinical Research
    Ohmann, Christian
    Bruns, Insa
    Wolff, Stephanie
    ONKOLOGIE, 2010, 33 : 11 - 15
  • [4] The Coordinating Centres for Clinical Trials Network
    Bruns, I.
    Maier-Lenz, H.
    Wolff, S.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2009, 52 (04) : 451 - 458
  • [5] Canadian Clinical Trials Coordinating Centre
    Tholl, Bill
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : 1170 - 1170
  • [6] Clinical Trial Metrics: The Complexity of Conducting Clinical Trials in North American Cancer Centers
    Lee, Carrie
    Werner, Theresa L.
    Deal, Allison M.
    Krise-Confair, Cassandra J.
    Bentz, Tricia Adrales
    Cummings, Theresa M.
    Grant, Stefan C.
    Lee, Ashley Baker
    Moehle, Jessica
    Moffett, Kristie
    Peck, Helen
    Williamson, Stephen
    Zafirovski, Aleksandar
    Shaw, Kate
    Hofacker, Janie K.
    JCO ONCOLOGY PRACTICE, 2021, 17 (01) : 40 - +
  • [7] The role of the data coordinating center in the IRB review and approval process: the DIG trial experience
    Collins, JF
    Garg, R
    Teo, KK
    Williford, WO
    Howell, CL
    CONTROLLED CLINICAL TRIALS, 2003, 24 (06): : 306S - 315S
  • [8] THE COORDINATING CENTER IN A CLINICAL-TRIAL
    CURB, JD
    HAWKINS, CM
    SMITH, EO
    ZIMBALDI, N
    FORD, C
    CARTER, B
    COOPER, C
    CONTROLLED CLINICAL TRIALS, 1981, 2 (01): : 83 - 83
  • [9] FUNCTIONAL EQUALITY OF COORDINATING CENTERS IN A MULTICENTER CLINICAL-TRIAL - EXPERIENCE OF THE INTERNATIONAL MEXILETINE AND PLACEBO ANTIARRHYTHMIC CORONARY TRIAL (IMPACT)
    ALAMERCERY, Y
    WILKINS, P
    KARRISON, T
    CONTROLLED CLINICAL TRIALS, 1986, 7 (01): : 38 - 51
  • [10] COORDINATING CLINICAL-TRIALS - THE ROLE OF THE STUDY COORDINATOR
    NICHOLS, LA
    JIMENEZ, CA
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1407 - 1407